These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36358610)
41. Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer. Jia S; Li L; Xie L; Zhang W; Zhu T; Qian B Front Genet; 2021; 12():666396. PubMed ID: 33936178 [TBL] [Abstract][Full Text] [Related]
42. Expression of Zhang X; Nie X; Long J; Yu J; Zhang P; Liu Y; Wu X; Bai Y; Mao J; Liu X; Yuan Y; Zhao H; Li L Ann Transl Med; 2020 Jul; 8(13):819. PubMed ID: 32793664 [TBL] [Abstract][Full Text] [Related]
43. Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma. Zhang J; Zhang C; Liu X; Sun N; Zhang C; Li R; Zhang Z Transl Cancer Res; 2020 May; 9(5):3293-3302. PubMed ID: 35117696 [TBL] [Abstract][Full Text] [Related]
44. High Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629 [TBL] [Abstract][Full Text] [Related]
45. A Novel Tool for the Risk Assessment and Personalized Chemo-/Immunotherapy Response Prediction of Adenocarcinoma and Squamous Cell Carcinoma Lung Cancer. Chen H; Xu X; Ge T; Hua C; Zhu X; Wang Q; Yu Z; Zhang R Int J Gen Med; 2021; 14():5771-5785. PubMed ID: 34557029 [TBL] [Abstract][Full Text] [Related]
46. A comparison of mRNA and circRNA expression between squamous cell carcinoma and adenocarcinoma of the lungs. Yu M; Tian Y; Wu M; Gao J; Wang Y; Liu F; Sheng S; Huo S; Bai J Genet Mol Biol; 2020; 43(4):e20200054. PubMed ID: 33196759 [TBL] [Abstract][Full Text] [Related]
47. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer. Tian WJ; Liu SS; Li BR Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552 [TBL] [Abstract][Full Text] [Related]
48. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma. Liu X; Chen L; Zhang T Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532 [TBL] [Abstract][Full Text] [Related]
49. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma. Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732 [TBL] [Abstract][Full Text] [Related]
50. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
51. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma. Li L; Liu YD; Zhan YT; Zhu YH; Li Y; Xie D; Guan XY Thorac Cancer; 2018 Jul; 9(7):775-784. PubMed ID: 29722145 [TBL] [Abstract][Full Text] [Related]
52. Systemic Analyses of the Expression of TPI1 and Its Associations with Tumor Microenvironment in Lung Adenocarcinoma and Squamous Cell Carcinoma. Yang X; Ye C; Zheng H; Dai C; Zhu Y Dis Markers; 2022; 2022():6258268. PubMed ID: 35126788 [TBL] [Abstract][Full Text] [Related]
53. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma. Hou G; Lu Z; Bi Y; Deng J; Yang X Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321 [TBL] [Abstract][Full Text] [Related]
54. Expression and Clinical Significance of lncRNA OSER1-AS1 in Peripheral Blood of Patients with Non-Small Cell Lung Cancer. Chen P; Qin Z; Sun X; Yang J; Lv J; Diao M Cells Tissues Organs; 2022; 211(5):589-600. PubMed ID: 34525476 [TBL] [Abstract][Full Text] [Related]
55. Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma. He J; Gao R; Meng M; Yu M; Liu C; Li J; Song Y; Wang H Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769557 [TBL] [Abstract][Full Text] [Related]
56. Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma. Al-Marsoummi S; Pacella J; Dockter K; Soderberg M; Singhal SK; Vomhof-DeKrey EE; Basson MD Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987632 [TBL] [Abstract][Full Text] [Related]
57. Identification of Potential Long Non-coding RNA Expression Quantitative Trait Methylations in Lung Adenocarcinoma and Lung Squamous Carcinoma. Wu X; Gao Y; Bu J; Deng L; Zhang P; Chi M; Jiang L; Shi X; Ning S; Wang G Front Genet; 2020; 11():602035. PubMed ID: 33362860 [TBL] [Abstract][Full Text] [Related]
58. Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168 [TBL] [Abstract][Full Text] [Related]
59. Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma. Zhu J; Wang M; Hu D PeerJ; 2020; 8():e8288. PubMed ID: 31938577 [TBL] [Abstract][Full Text] [Related]
60. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis. Zhang LX; Gao J; Long X; Zhang PF; Yang X; Zhu SQ; Pei X; Qiu BQ; Chen SW; Lu F; Lin K; Xu JJ; Wu YB Mol Cancer; 2022 May; 21(1):110. PubMed ID: 35525959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]